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AbstrAct
Routine quantitative electromyography is used for the assessment of the presence of lower motor neurone involvement and 
its consequences, including primary denervation and compensatory reinnervation of muscle fibres. However, it is not useful 
for the assessment of the motor unit number reserve. The need for a valid biomarker to evaluate lower motor neurone disease 
progression in such diseases as amyotrophic lateral sclerosis, and for use in clinical trials, has led to a number of studies of the 
methods that allow assessment of the number of motor units. In this review, motor unit number estimation (MUNE) methods 
with incremental stimulation and the recently developed motor unit number index (MUNIX) method, along with their technical 
and clinical aspects, are presented as methods which reflect motor unit loss in neurogenic processes. These electrodiagnostic 
tests may allow a valuable assessment of disease progression and the efficacy of new therapeutic methods in clinical trials in 
diseases with lower motor neurone degeneration. 
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Introduction
Routine quantitative needle electromyography (EMG) is 
used for the assessment of the presence of lower motor neurone 
involvement and its consequences, such as primary denervation 
and compensatory reinnervation of muscle fibres. However, it 
is not useful for the evaluation of the number of motor units. 
In neurogenic processes such as amyotrophic lateral sclerosis 
(ALS), abnormal needle EMG recording reflects the effects 
of two overlapping processes that occur in the muscles: acute 
denervation and reinnervation. In the initial stage of the 
disease, the loss of anterior horn cells results in acute motor 
fibre denervation. Afterwards, in the stage of secondary muscle 
fibre innervation, this denervation is compensated by sprouting 
axonal collaterals from surviving motor units into denervated 
muscle fibres. Routinely, the concentric needle electrode used 
in EMG records the combined action potentials generated 
by several fibres within a motor unit territory of 5–15 mm. 
This is known as the motor unit activity potential, or MUAP). 
MUAP parameters are increased in the stage of secondary 
reinnervation. This occurs due to an enlarged motor unit area 
and dispersion, which results from differences in the duration 
of potential components caused by abnormal neuromuscular 
transmission in immature axonal collaterals. Finally, in the 
stage of decompensation, MUAP parameters decrease due to 
continuous loss of motor units and a decrease in their area. 
Neurophysiological changes in motor units in ALS undergo 
continuous evolution along with a dynamic reorganisation. 
Due to these overlapping processes, MUAP parameters 
do not appear to correlate with clinical muscle dysfunction. 
Pseudo-normal MUAP parameters may be observed even in 
the terminal stage of the disease, because MUAP parameters 
do not reflect the motor unit number but rather the effect of 
the denervation-reinnervation processes. 
It is worth pointing out that conventional EMG abnor-
malities reveal denervation and reinnervation changes caused 
by lower motor neurone degeneration, but do not reflect the 
actual motor unit number.
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Motor unit number estimation
The importance of the motor unit as a crucial element in 
the production of force and movement was first recognised by 
Sherrington [1]. Subsequently, numerous studies have dealt 
with the structure and function of motor units. Studies on the 
methods estimating the number of motor units in individual 
muscles are still needed because there is a need for a valid 
biomarker to assess disease progression and to estimate po-
tential treatment effects. 
In 1971, McComas et al. described an attractively simple 
method for counting motor units. Recording from the extensor 
digitorum brevis, the authors maximally stimulated the deep 
peroneal nerve at the ankle and obtained a maximal compound 
motor action potential (CMAP) [2].
Then, starting from subthreshold stimulation levels, they 
gradually increased stimulus intensity until a quantal response 
was seen, representing the first motor unit activated. With 
further stimulus intensity increases, quantal increases in the 
response were recorded. Up to 11 discrete increments were 
recorded, with each increment assumed to represent the addi-
tion of one motor unit. The amplitude of the resultant response 
was divided by the number of increments to yield an estimate 
of the amplitude of a single unit; this value was divided by 
the maximum CMAP to give the estimate of the number of 
motor units. The incremental motor unit number estimation 
(MUNE) technique was soon applied to upper extremity 
muscles supplied by median, ulnar and radial nerves [3–5]. 
MUNE techniques have been used to quantify the propor-
tion of surviving lower motor neurones in ALS. The results 
of multiple studies have confirmed that MUNE, when applied 
longitudinally, may reflect the rate of disease progression [6–9]. 
Assuming that the maximal CMAP is the sum of all sin-
gle motor unit potentials, the universal rule for MUNE with 
incremental stimulation is that MUNE may be calculated as 
a ratio: the average size of a surface-detected single motor unit 
action potential (SMUP) should be divided by the maximum 
CMAP. SMUP is acquired by averaging several potentials of an 
increased amplitude with stimulation of an increasing intensity 
using the ‘all or none’ method. 
Many techniques for estimating the average amplitude of 
single motor units have been suggested, but most have been 
limited by sampling bias and/or a lack of reproducibility. 
Different techniques for MUNE have been practiced, among 
them the spike-triggering averaging method using a voluntary 
muscle contraction to activate the motor unit, and the multiple 
point stimulation method with stimulation at multiple sites 
along the nerve. 
One of the MUNE methods, with incremental stimulation 
in Shefner’s modification, starts by obtaining CMAP in the 
most distal point with a maximal amplitude using supramaxi-
mal stimuli. During the second step of the test, the stimulating 
electrode is positioned in the following three locations: at the 
wrist crease; 4 cm proximal to the wrist crease; and in the 
cubital fossa [6, 10]. A standard three-site motor conduction 
programme is used with traces set to superimpose.
Then, subthreshold stimuli are applied at the rate of 1/s, 
with stimulus intensity slightly increased until an ‘all or none’ 
response is recorded. For both initial and incremental respon-
ses, the minimum negative peak amplitude considered to be 
acceptable for recording is 25 µV. When the initial response has 
been obtained, two more incremental responses (of more than 
25 µV) are recorded. Stimulus location is then moved to the 
second and third sites, and the same procedure of incremental 
stimulation is repeated [8] (Fig. 1).
The amplitude of three maximal responses from the three 
sites is totalled and divided by 9 to obtain the mean amplitude 
of an average surface-detected SMUP. The maximum CMAP 
amplitude is then divided by the SMUP amplitude to calculate 
the number of motor units [6, 10]. 
From the practical point of view, MUNE has some 
advantages. For example, it is not invasive and it is not 
unpleasant for the patient because only CMAP is obtained 
with a supramaximal impulse, and subsequent responses for 
a single motor unit are obtained with a very low current. For 
MUNE, cooperation with the patient is not required, so it 
can be used even in small children [11]. However, MUNE 
also has the disadvantage that it is useful only for the distal 
muscles. Due to response variability, extensive experience is 
needed to ensure that the proper curve is selected and the 
result is valid. Opinions have been voiced that the traditional 
Figure 1. The second step in MUNE calculation: Three incremental 
responses in three sites of stimulations of the ulnar nerve (motor 
potentials)
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stimulation-based MUNE techniques are technically challen-
ging, time consuming, and potentially limited by motor unit 
instability [12–13].
For these reasons, a surface-based electromyography 
MUNE technique that does not require nerve stimulation, 
something that has been termed the motor unit number index 
(MUNIX), has been developed in order to overcome some of 
the limitations of the MUNE method [13]. 
Motor unit number index 
The MUNIX method is one of the recently developed elec-
trophysiological approaches which may provide information 
about the degree of motor unit loss[14]. The MUNIX technique 
is a means of expressing the number of active motor units in 
a muscle as an index, rather than providing a direct measure 
of their total number [15]. 
MUNIX is a non-invasive method that can be applied to 
any muscle in which CMAP can be evoked by supramaximal 
nerve stimulation. The result of the examination is directly 
related to the number of functioning motor neurones in 
a given muscle. MUNIX uses a mathematical model based on 
CMAP and the surface interference pattern (SIP) following 
their import into an analysis software created by Nandedkar 
et al. [14, 16]. 
In the first step of MUNIX, a supramaximal CMAP is 
obtained by a standard tendon belly application of the surface 
electrodes to optimise the amplitude of the motor potential. 
Because obtaining maximal CMAP is crucial for the MU-
NIX result, it is recommended to reposition the recording 
electrode up to 5 times in order to record an optimised 
CMAP [17–18]. 
The next step is EMG signal recording during voluntary 
effort. The patient activates the examined muscle by resisting 
the examiner in an isometric contraction. It is recommended 
to avoid isotonic contraction and limb movement. The EMG 
signals should have spikes with an amplitude of 200 µV or 
more. The force is increased from minimal to maximal in 
5–9 steps. At each force level, the patient maintains a steady 
contraction while SIP is recorded. The area and power of the 
CMAP and SIP are used to calculate the ideal case motor unit 
count (ICMUC). The MUNIX results are calculated using 
an automated method. The result is presented as a plot and 
a numeric value reflecting the number and size of motor units 
recruited at various force levels [18] (Fig. 2A, B).
Just as in MUNE with the incremental stimulation method, 
a strong correlation between CMAP amplitude and MUNIX in 
healthy controls has been found (Fig. 3). However, recurrent 
stimuli could result in habituation and a decreased potential 
amplitude, and thus intervals between the stimuli are required. 
A lower, underestimated CMAP amplitude has a dramatic 
effect on the reduction of MUNIX. When a potential is recor-
ded with a stimulus artifact, the power cannot be measured 
accurately. Due to the need to perform a gradual effort, a good 
cooperation with the patient is crucial. 
Our results suggest that MUNIX is a method that could be 
useful not only for the estimation of disease progression but 
also as a complementary method for the initial assessment of 
muscle [19]. From a practical point of view, the global MUNIX 
seems to be more useful for general patient assessment. 
Figure 2 A. The surface electromyography interference pattern (SIP) of abductor digiti minimi is recorded when the patient maintains a con-
stant isometric force of contraction at different force levels. This is used in conjunction with the CMAP to compute the so-called ‘ideal case 
motor unit count (ICMUC)’. B. A plot of ICMUC versus SIP area is made, and the relationship of data points is modelled as a power regression 
equation and the MUNIX is calculated (from the own archives of EMG Laboratory) [14]
A b
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Use of MUNIX in amyotropic lateral  
sclerosis and other neurogenic processes 
Amyotrophic lateral sclerosis is an adult-onset, progressive 
lethal neurodegenerative disorder characterised by a selective 
dysfunction and loss of upper and lower motor neurones. It 
leads to quadriplegia and respiratory insufficiency within a few 
years from the onset of initial symptoms. ALS shows a cha-
racteristic variability of onset and rate of disease progression 
which, together with a clinical heterogeneity, makes quantifi-
cation of the symptoms problematic. It is therefore important 
to develop strategies that would allow objective assessment of 
the disease progression and the prediction of outcomes. The 
diagnosis of ALS is based on a clinical evaluation together 
with conventional EMG [20–21]. 
Amyotrophic lateral sclerosis
The reliability and sensitivity of MUNIX as a tool to mo-
nitor the progression of motor unit loss during the course of 
the disease in ALS patients has been reported in many studies. 
Some of them focused only on a single muscle. In the study 
by Boekestein, the MUNIX and HD-MUNE (high density 
MUNE) of the thenar muscle was evaluated. Patients with 
ALS were assessed at baseline, within two weeks, and after 
four and eight months. There was a significant positive cor-
relation between MUNE and MUNIX values in ALS patients. 
After eight months, both MUNE and MUNIX values in the 
ALS patients had decreased significantly more compared to 
the Medical Research Council (MRC) scale, ALS functional 
rating scale (ALSFRS), and CMAP (p < 0.05) [22].
In the study by Fathi, MUNIX was recorded in the ab-
ductor pollicis brevis and tibialis anterior muscles bilaterally 
in ALS patients, with two measurements, one at the first visit 
and the second at a follow-up visit. The consistency of repro-
ducibility of MUNIX in 30 ALS patients during the course of 
the disorder was analysed. A significant correlation between 
the first and the second MUNIX measurement in all tested 
muscles was found. A statistically significant good reprodu-
cibility of MUNIX in all four measured muscles was obtained 
at the follow-up visit [23]. 
Even more valuable are studies with several MUNIX exa-
minations assessing disease progress and with evaluation of 
the distal as well as proximal muscles. 
In a large clinical trial (27 centres participating in the 
Biogen study, 792 individual test-retest measurements), 
MUNIX was measured in a set of six muscles: the abduc-
tor pollicis brevis, abductor digiti minimi, first dorsal 
interosseous, biceps brachii, tibialis anterior, and extensor 
digitorum brevis. The aim was to analyse the reliability of 
MUNIX measurements and possible pitfalls in implementing 
the method in clinical trials. Mean coefficient of variation 
(COV) of all raters at the first measurements was 12.9% 
±  13.5% (median 8.7%). The need for repeated tests ranged 
from 0 to 43 (mean 10.7  ±  9.1, median 8). The biceps brachii 
muscles showed the highest repetition rates. Evaluation of 
the biceps brachii failed in approximately two thirds of cases 
due to contamination of the CMAP by co-stimulation of 
other nearby nerves, such as the musculocutaneous nerve, 
with volume conducted signals from wrist and finger flexors 
or even the triceps muscle. MUNIX variability correlated 
considerably with the variability of CMAP. The authors 
concluded that MUNIX showed generally good reliability, 
but was rater-dependent and that ongoing support for the 
raters was needed [24]. 
Neuwirth et al. reported the rate of MUNIX decline in 
ALS during a series of examinations at three-month inter-
vals after the diagnosis. Three centres measured MUNIX in 
49 ALS patients every three months in six muscles (abductor 
pollicis brevis, abductor digiti minimi, biceps brachii, tibialis 
anterior, extensor digitorum brevis, and abductor hallucis) 
on the less affected side. The decline in MUNIX in initially 
non-wasted, clinically strong muscles (manual muscle test-
ing, MMT grade 5) was analysed before and after the onset 
of weakness. The average monthly relative MUNIX loss was 
5.0% before, and 5.6% after, the onset of weakness. Although 
the preclinical loss of motor units is a well-known feature 
of ALS and can be detected by needle EMG very early in the 
course of the disease even in a clinically normal muscle, MU-
NIX seems to be a valuable measurable marker of preclinical 
abnormalities. In that study, the rate of MUNIX change was 
significantly higher compared to the ALS functional rating 
scale ALSFRS and CMAP change over 12 months prior to 
the onset of muscle weakness. This makes MUNIX a good 
Figure 3. A strong correlation was found between CMAP amplitude 
and MUNIX results in healthy controls [14]
255www.journals.viamedica.pl/neurologia_neurochirurgia_polska
Małgorzata Gaweł, MUNE and MUNIX review
biomarker candidate for disease progression, and possibly 
pharmacodynamic response [25]. 
In one of our studies, we analysed MUNIX in ALS patients 
(15 patients) and we found a significant correlation between 
the global MUNIX score and the clinical dysfunction as me-
asured by the ALSFRS-R scale (P < 0.05). The global MUNIX 
score showed a higher monthly decline (4.3%) compared to 
ALFRS-R (0.7%) and the MRC global score (0.5%). This study 
also confirmed that the MUNIX method is a sensitive, reliab-
le, and accurate tool reflecting both motor dysfunction and 
disease progression in ALS. We have found this approach to 
be more reliable and technically easier in distal muscles with 
less atrophy and a better strength. 
The results of our study suggest that MUNIX is a method 
that may be useful not only for estimation of disease progres-
sion but also as a complementary method for initial muscle 
assessment. We also made some practical observations. The 
MUNIX method may be affected by an inappropriate CMAP 
recording caused by technical or anatomical problems. It is 
crucial to find the optimal location of the recording electro-
de, and to repeat CMAP recording to ensure that the motor 
response with a maximal amplitude is obtained. A lower, 
underestimated CMAP amplitude has a dramatic effect on 
the reduction of MUNIX. When a potential is recorded with 
a stimulus artifact, the power cannot be measured accurately 
and the same problem affects MUNIX too [19]. 
To date, the usefulness of this method for assessing the 
dynamics of disease-related changes has been studied mainly 
in non-treated subjects. One of the most recent studies focu-
sed on choosing an optimal monitoring tool after intraspinal 
transplantation of adipose tissue-derived regenerative cells in 
three patients with amyotrophic lateral sclerosis. The treatment 
did not prove effective in terms of reversing or delaying disease 
progression, but a number of observations were made. Of all 
methods used, MUNIX proved to be the first and the most 
sensitive tool for identifying fine changes at the muscle level. 
It was markedly more sensitive than ALSFRS R and MRC. 
In that study, dynamometry was the closest measurement to 
MUNIX both in the upper and the lower limb [26].
Spinal muscular atrophy
In one of the most recent studies, hand muscle innervation 
pattern was studied by the MUNIX method in 38 adult patients 
with genetically confirmed 5q spinal muscular atrophy (SMA). 
Data was compared to that of healthy controls and ALS pa-
tients and correlated with typical disease-relevant scores and 
other clinical and demographic characteristics. By calculation 
of the MUNIX ratios, the authors identified a specific hand 
muscle wasting pattern for SMA which is different to the 
split hand in ALS. MUNIX parameters strongly correlated 
with established disease course parameters, independently of 
disease stages [27]. 
Polyneuropathy
The MUNIX technique was also assessed unilaterally in 
the abductor digiti minimi, the abductor pollicis brevis, and 
the tibialis anterior muscles in 14 patients with chronic inflam-
matory demyelinating polyradiculoneuropathy (CIDP) on two 
different occasions by two blinded examiners, and the MUNIX 
score was calculated by adding the results for the abductor 
digiti minimi, the abductor pollicis brevis, and the tibialis 
anterior muscles. The intraclass correlation coefficient (ICC) 
was high for inter- and intravariability for all three examined 
muscles, and the combined MUNIX scores from the first and 
the second evaluations were strongly correlated to each other. 
The MUNIX score was significantly correlated with MRC tes-
ting and also with the overall neuropathy limitation scale and 
the Rasch-built overall disability scale. The authors concluded 
that the MUNIX technique estimates the axonal loss and the 
number of functional motor units and that the MUNIX score 
may be a good instrument to evaluate CIDP patients during 
their follow-up [28]. 
In one study, a short-term effect of intravenous immuno-
globulins (IVIg) in multifocal motor neuropathy (MMN) was 
evaluated using MUNIX. MUNIX was assessed longitudinally 
in seven MMN patients and 17 healthy controls in the abductor 
pollicis brevis and abductor digiti minimi muscles. All MMN 
patients were evaluated on the first day of IVIg infusion, five 
MMN patients were evaluated 22 days after IVIg infusion, 
and three MMN patients were evaluated one month after two 
IVIg infusions. The authors concluded that MUNIX seems to 
be a reliable and sensitive tool for monitoring the short-term 
efficacy of IVIg in MMN [29]. 
MUNE or MUNIX
Interestingly, in the study by Higashihara, evaluation by 
MUNE with multipoint stimulation and MUNIX was per-
formed in 15 healthy subjects at three different time-points 
by the same examiner. ICC and COV values for MUNIX 
and MUNE were excellent across the three tests (0.80 and 
0.77, respectively), although COV values were significantly 
lower for MUNIX than for MUNE (P < 0.01). In addition, 
the test-retest reproducibility was better for MUNIX, a fin-
ding largely attributable to poor reproducibility of the single 
motor unit action potential area. The authors concluded that 
MUNIX demonstrated better intra-rater reproducibility and 
may be a more reliable neurophysiological biomarker than 
MUNE [30]. 
In conclusion, MUNIX seems to be valuable tool for 
monitoring the progression of diseases with neurogenic pro-
cesses. While multiple studies have confirmed the usefulness 
of MUNIX for monitoring ALS progression, the application 
of MUNIX in other diseases with lower motor neurone dege-
neration needs further assessment. 
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MUNIX is recommended because it shows good repeata-
bility, is less time-consuming, can be used for both distal and 
proximal muscles, and requires less electrical stimulation. 
However, currently there are only few pharmacological studies 
using MUNIX which would test the utility of this approach. 
MUNE with incremental stimulation can be recommended 
for the distal muscles, and for those occasions when there 
is no possibility of patient cooperation. The crucial issue 
regarding the application of both MUNIX and MUNE is the 
electromyographist’s experience and his or her attention to 
some very important technical aspects. 
Ethics committee approval was not necessary for prepa-
ration of this article.
The author reports no sources of funding.
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